FIELD: immunology.
SUBSTANCE: present invention relates to the field of immunology. A method for cancer treatment is proposed, which provides for a combination therapy that includes an OX40 agonist and a 4-1BB agonist.
EFFECT: present invention can find further application in the therapy of various types of cancer.
6 cl, 1 dwg, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OX40 BINDING POLYPEPTIDES AND THEIR USE | 2019 |
|
RU2802070C2 |
| ANTIBODIES AGAINST TNFRSF9 AND THEIR USE | 2019 |
|
RU2812200C2 |
| COMBINATION | 2015 |
|
RU2744841C2 |
| MULTI-SPECIFIC ANTIBODIES AND METHODS OF THEIR PRODUCTION AND USE | 2018 |
|
RU2811477C2 |
| ANTIBODIES AGAINST OX40 AND THEIR USE | 2017 |
|
RU2783314C2 |
| ANTI-TIGIT ANTIBODIES AND METHODS OF USING | 2016 |
|
RU2732591C2 |
| ANTIBODY MOLECULES THAT BIND CD137 AND OX40 | 2019 |
|
RU2817602C2 |
| ANTI-TIGIT ANTIBODIES AND METHODS OF USE | 2016 |
|
RU2817838C2 |
| BISPECIFIC ANTIBODIES SPECIFIC RELATIVELY TO COSTIMULATORY TNF-RECEPTOR | 2016 |
|
RU2761115C1 |
| ANTI-OX40 ANTIBODIES AND THEIR APPLICATION | 2017 |
|
RU2753493C2 |
